A clinical trial to investigate the factors affecting adverse drug reactions and clinical efficacy of clozapine in Korean

Kyung Hee University0 个研究点目标入组 100 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•?Patients who can provide their written informed consents according to GCP and related regulations
•?Men and women over the age of 19
•?Patients who are diagnosed as schizophrenia spectrum disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and expected to use clozapine for more than 57 days(More than 14 days after the last dose of clozapine in patients who previously used clozapine)
•?Patients who understand the contents of the clinical research explanations and have given written informed consents

•? Patients who took a drug that the investigator deemed inappropriate before clozapine administration within 2 weeks before screening. (which may be acceptable if the investigator considers to have no effect on pharmacokinetics or safety of the study drug)
•? Patients who are planning a pregnancy or who can not use approved methods for contraception during the study period
•? Patients who are considered to be inappropriate for study participation by the investigator based on other reasons including clinical laboratory test results

发起方